Vesugen vs MOTS-c
Side-by-side comparison of Vesugen and MOTS-c: mechanism, half-life, dose range, safety profile, and vendor pricing.
Price snapshot
Vesugen
MOTS-c
Vesugen
Vesugen is a short synthetic peptide developed within Vladimir Khavinson's laboratory at the Saint Petersburg Institute of Bioregulation and Gerontology and marketed in Russia as an oral capsule for vascular and…
No vendor price on file.
Full Vesugen profileMOTS-c
MOTS-c (Mitochondrial ORF of the Twelve S rRNA type-c) is a 16-amino-acid mitochondrial-derived peptide — a member of a recently discovered class of small peptides encoded in mitochondrial DNA rather than nuclear DNA. It…
Lowest listed price: $44.99 across 9 listings
Full MOTS-c profileSide-by-side comparison
| Attribute | Vesugen | MOTS-c |
|---|---|---|
| Category | Recovery | Longevity & Cellular Health |
| Research Stage | Preclinical | Preclinical |
| Mechanism of Action | Vesugen's proposed mechanism follows the three-stage Khavinson short-peptide framework. At the pharmacokinetic level, oral dosing is claimed to produce sufficient intact peptide absorption to deliver bioactive quantities to target tissues. Mechanistic work… | A New Class of Signaling Molecule MOTS-c belongs to the mitochondrial-derived peptides (MDPs) - a class of small peptides encoded within mitochondrial DNA open reading frames that were historically thought to encode only ribosomal RNAs. The known MDPs include:… |
| Half-Life | Not established in humans. As a short tripeptide, KED is expected to be rapidly hydrolyzed in plasma, with an anticipated half-life on the order of minutes; no formal pharmacokinetic study of Vesugen has been published. | ~4–6 hours |
| Typical Dose Range | 20 mg oral capsule 1-2 daily for 10-day cycles (60-90 day washout) | 5,000–10,000 mcg (5–10 mg) per injection |
| Dosing Frequency | 1-2 capsules daily during the 10-day cycle | 2-3 times per week |
| Administration | — | Subcutaneous, Intramuscular |
| Side Effects | Published Khavinson-group observations describe Vesugen as well tolerated at the recommended oral dose of 1 to 2 capsules daily during a 10-day cycle. Specific adverse events noted include occasional mild gastrointestinal discomfort (nausea, loose stools)… | Reported Effects (limited human data) - Injection site reactions — Mild erythema, transient itching at SC injection site. Site rotation minimizes. Probably the single most reported issue. - Transient fatigue — Some users report mild fatigue in the first week… |
| Molecular Weight | 390.39 g/mol | 2174 Da |
| Common Vial Sizes | — | 5mg, 10mg |
Price History
5 data points- OF
- BM
- Half Nattys
- Ion Peptide
- Disguised Alpha
- BHG Labs
Vesugen: potential benefits
- Vascular health support
- Blood vessel integrity maintenance
- Endothelial function optimization
- Cardiovascular anti-aging
MOTS-c: potential benefits
- Insulin sensitivity
- Exercise mimicry
- Metabolic health
- Anti-aging
- Fat oxidation
- Longevity
Frequently asked
What's the difference between Vesugen and MOTS-c?
Vesugen is a recovery that vesugen's proposed mechanism follows the three-stage khavinson short-peptide framework. at the pharmacokinetic level, oral dosing is claimed to produce sufficient intact peptide…. MOTS-c is a longevity & cellular health that a new class of signaling molecule mots-c belongs to the mitochondrial-derived peptides (mdps) - a class of small peptides encoded within mitochondrial dna open reading frames that…. The two differ in mechanism, half-life (Not established in humans. As a short tripeptide, KED is expected to be rapidly hydrolyzed in plasma, with an anticipated half-life on the order of minutes; no formal pharmacokinetic study of Vesugen has been published. vs ~4–6 hours), and typical dose range.
Which has the longer half-life, Vesugen or MOTS-c?
Vesugen has a half-life of Not established in humans. As a short tripeptide, KED is expected to be rapidly hydrolyzed in plasma, with an anticipated half-life on the order of minutes; no formal pharmacokinetic study of Vesugen has been published.. MOTS-c has a half-life of ~4–6 hours. Longer half-lives generally mean less frequent dosing but slower on/off kinetics.
Can you stack Vesugen and MOTS-c?
Stacking depends on mechanism overlap, safety profile, and goals. Vesugen and MOTS-c should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.
See current vendor prices
Listings from the vendors we track. Prices change often, so check the vendor before you buy.
Before you buy Vesugen or MOTS-c
Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.
Related comparisons
Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. Every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.